MedPath
NMPA Approval

Levothyroxine Sodium Tablets

国药准字HJ20255001

January 13, 2025

国药准字HJ20140052

Drug Information

左甲状腺素钠片

优甲乐

片剂

25μg(以左甲状腺素钠计)

化学药品

January 13, 2025

February 5, 2029

Company Information

Applicant Company

MERCK SANTE S.A.S

37 rue Saint Romain 69379 LYON CEDEX 08 – FRANCE

Manufacturing Company

Frankfurter Straβe 250 64293 Darmstadt Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左甲状腺素钠片 - NMPA 批准文号 | MedPath